Tag: Dr. Rickard
News alerts
Latest content
- Ipsen announces new data on Dysport in neurological disease

- PMGroup Worldwide Ltd welcomes MAD World Summit

- Argenx receives review from FDA for VYVGART in seronegative gMG

- Nuclera extends Series C funding to advance antibody engineering

- Cellistic launches new iPSC-based platforms to expand immuno-oncology therapies

Contact details
PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
